AstraZeneca shares dropped Tuesday after a report that dozens of the company’s senior executives in China potentially have ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was ...

Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global ...

The president of AstraZeneca’s China division has been placed under investigation by local police, as Beijing advances an anti-corruption crackdown in the healthcare sector ...

AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...